These findings suggest that puerarin, likely through PI3K/AKT pathway inhibition, effectively suppresses 740 Y-P-induced EMT, migration, and invasion in Caco-2 cells, potentially limiting colon cancer cell metastasis. Here, AKT1 is linked to malignant colon neoplasm.